ILUVATAR COREX (09903) and Shanghai Guosheng Established a Private Equity Fund, Completing Industrial and Commercial Registration
Industrial and commercial registration information shows that the fund has a total subscribed capital contribution of RMB502 million and adopts a dual general partner structure, with Shanghai Guosheng Capital Management Co., Ltd., a subsidiary of Guosheng Group, and Shanghai Tianshu Qichen Business Consulting Co., Ltd., a wholly-owned subsidiary of ILUVATAR COREX, jointly performing the roles.
GMTEight APP, based on public information from Qichacha, reports that Shanghai Shengqi Intelligent Computing Private Equity Investment Fund Partnership (Limited Partnership), established with the joint participation of ILUVATAR COREX (09903) and Shanghai Guosheng Capital Management Co., Ltd., a subsidiary of Guosheng Group, completed its industrial and commercial establishment registration on November 19, 2026.
Industrial and commercial registration information shows that the fund has total subscribed capital contributions of RMB502 million and adopts a dual general partner structure, with Shanghai Guosheng Capital Management Co., Ltd., a subsidiary of Guosheng Group, and Shanghai Tianshu Qichen Business Consulting Co., Ltd., a wholly-owned subsidiary of ILUVATAR COREX, jointly performing the roles. In the contributor structure, Shanghai State-owned Enterprise Reform and Development Phase III Private Equity Investment Fund accounts for 39.84%, Shanghai ILUVATAR COREX Semiconductor Co., Ltd. accounts for 29.88%, and the remaining shares are subscribed by multiple industrial capital entities.
Related Articles

Sirtex completes acquisition of FDA-cleared Hourglass, GRAND PHARMA (00512) further upgrades its precision intervention ecosystem synergy capabilities

Beijing Relpow Technology (300593.SZ)'s private placement application accepted by the Shenzhen Stock Exchange

TKD Science and Technology (603738.SH) plans to launch a 2026 employee stock ownership plan.
Sirtex completes acquisition of FDA-cleared Hourglass, GRAND PHARMA (00512) further upgrades its precision intervention ecosystem synergy capabilities

Beijing Relpow Technology (300593.SZ)'s private placement application accepted by the Shenzhen Stock Exchange

TKD Science and Technology (603738.SH) plans to launch a 2026 employee stock ownership plan.






